1. Home
  2. OVID vs NTZ Comparison

OVID vs NTZ Comparison

Compare OVID & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • NTZ
  • Stock Information
  • Founded
  • OVID 2014
  • NTZ 1959
  • Country
  • OVID United States
  • NTZ Italy
  • Employees
  • OVID N/A
  • NTZ N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • OVID Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • OVID Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • OVID 54.1M
  • NTZ 51.8M
  • IPO Year
  • OVID 2017
  • NTZ 1993
  • Fundamental
  • Price
  • OVID $0.74
  • NTZ $4.91
  • Analyst Decision
  • OVID Strong Buy
  • NTZ
  • Analyst Count
  • OVID 5
  • NTZ 0
  • Target Price
  • OVID $4.04
  • NTZ N/A
  • AVG Volume (30 Days)
  • OVID 384.9K
  • NTZ 15.4K
  • Earning Date
  • OVID 03-07-2025
  • NTZ 12-12-2024
  • Dividend Yield
  • OVID N/A
  • NTZ N/A
  • EPS Growth
  • OVID N/A
  • NTZ N/A
  • EPS
  • OVID N/A
  • NTZ N/A
  • Revenue
  • OVID $631,695.00
  • NTZ $365,846,531.00
  • Revenue This Year
  • OVID $71.38
  • NTZ N/A
  • Revenue Next Year
  • OVID $5,144.81
  • NTZ N/A
  • P/E Ratio
  • OVID N/A
  • NTZ N/A
  • Revenue Growth
  • OVID 113.21
  • NTZ N/A
  • 52 Week Low
  • OVID $0.68
  • NTZ $3.80
  • 52 Week High
  • OVID $4.10
  • NTZ $6.50
  • Technical
  • Relative Strength Index (RSI)
  • OVID 25.31
  • NTZ 56.77
  • Support Level
  • OVID $0.75
  • NTZ $4.63
  • Resistance Level
  • OVID $1.01
  • NTZ $4.93
  • Average True Range (ATR)
  • OVID 0.07
  • NTZ 0.33
  • MACD
  • OVID -0.02
  • NTZ 0.02
  • Stochastic Oscillator
  • OVID 6.25
  • NTZ 92.18

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.

Share on Social Networks: